Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10519130 Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Patent 10519130 was granted and assigned to FORMA Therapeutics on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

FORMA Therapeutics

0

Current Assignee

FORMA Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David R. Lancia, Jr.0

Stephanos Ioannidis0

Adam Charles Talbot0

Alexandre Joseph Buckmelter0

Ann-Marie Campbell0

Bruce Follows0

Minghua Wang0

Date of Patent

December 31, 2019

0

Patent Application Number

161791250

Date Filed

November 2, 2018

0

Patent Citations

US Patent 10377767 Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

US Patent 10000495 Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

US Patent 10351571 Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

US Patent 10377760 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

US Patent 10377773 Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

Patent Citations Received

US Patent 10927130 Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

US Patent 10981915 Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

US Patent 12018030 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

0

US Patent 10836741 Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

0

US Patent 10906916 Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

US Patent 10934299 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Patent Primary Examiner

0

Patent abstract

The present disclosure relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10519130 Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.